Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endocannabinoid system in neurodegenerative disorders
Balapal S. Basavarajappa, Madhu Shivakumar, Vikram Joshi, et al.
Journal of Neurochemistry (2017) Vol. 142, Iss. 5, pp. 624-648
Open Access | Times Cited: 184

Showing 1-25 of 184 citing articles:

Medical Use of Cannabinoids
Ana Isabel Fraguas‐Sánchez, Ana Isabel Torres‐Suárez
Drugs (2018) Vol. 78, Iss. 16, pp. 1665-1703
Closed Access | Times Cited: 231
Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity
Xavier Nadal, Carmen del Río, S. Casano, et al.
British Journal of Pharmacology (2017) Vol. 174, Iss. 23, pp. 4263-4276
Open Access | Times Cited: 108
Neuroprotective and Immunomodulatory Action of the Endocannabinoid System under Neuroinflammation
L.A. Kasatkina, Sonja Rittchen, Eva M. Sturm
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5431-5431
Open Access | Times Cited: 89
Histone Methylation Regulation in Neurodegenerative Disorders
Balapal S. Basavarajappa, Shivakumar Subbanna
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4654-4654
Open Access | Times Cited: 67
New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
Berhanu Geresu Kibret, Hiroki Ishiguro, Yasue Horiuchi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 975-975
Open Access | Times Cited: 46
Endocannabinoid System: Chemical Characteristics and Biological Activity
Bismarck Rezende, A Alencar, Graziele Freitas de, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 148-148
Open Access | Times Cited: 39
Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer’s Disease
Atefeh Afsar, Maria del Carmen Chacon Castro, Adedamola Saidi Soladogun, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7258-7258
Open Access | Times Cited: 24
The NLRP3 inflammasome: a vital player in inflammation and mediating the anti-inflammatory effect of CBD
Feng-xin Chu, Xiao Wang, Bo Li, et al.
Inflammation Research (2024) Vol. 73, Iss. 2, pp. 227-242
Closed Access | Times Cited: 13
A new frontier in neuropharmacology: Recent progress in natural products research for blood–brain barrier crossing
Ureña-Vacas Isabel, Aznar de la Riera M. Belén, Serrano Dolores R, et al.
Current Research in Biotechnology (2024) Vol. 8, pp. 100235-100235
Open Access | Times Cited: 11
A Disposable Pipette Extraction‐UHPLC‐MS/MS Method Based on Removal of Phospholipids to Determine Anandamide, 2‐Arachidonoylglycerol, Cannabidiol, and Δ9‐Tetrahydrocannabidiol in Plasma Samples
Igor Gustavo Carvalho Oliveira, Israel Donizéti de Souza, José Alexandre S. Crippa, et al.
Journal of Separation Science (2025) Vol. 48, Iss. 1
Closed Access | Times Cited: 1
Cannabidiol-Induced Autophagy Ameliorates Tau Protein Clearance
Talita Aparecida de Moraes Vrechi, Gabriel Cicolin Guarache, Rafaela Brito Oliveira, et al.
Neurotoxicity Research (2025) Vol. 43, Iss. 1
Open Access | Times Cited: 1
The Notch pathway in CNS homeostasis and neurodegeneration
Diana M. Ho, Spyros Artavanis‐Tsakonas, Angeliki Louvi
Wiley Interdisciplinary Reviews Developmental Biology (2019) Vol. 9, Iss. 1
Closed Access | Times Cited: 73
Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors
Siyu Ren, Zhen‐Zhen Wang, Yi Zhang, et al.
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 10, pp. 1263-1271
Open Access | Times Cited: 67
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
Alessandro Papa, Silvia Pasquini, Chiara Contri, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 471-471
Open Access | Times Cited: 29
Unlocking the Epigenetic Symphony: Histone Acetylation’s Impact on Neurobehavioral Change in Neurodegenerative Disorders
Balapal S. Basavarajappa, Shivakumar Subbanna
Epigenomics (2024) Vol. 16, Iss. 5, pp. 331-358
Closed Access | Times Cited: 8
Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer’s Disease
Hina Kanwal, Moris Sangineto, Martina Ciarnelli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4050-4050
Open Access | Times Cited: 7
Multiple Roles of Apolipoprotein E4 in Oxidative Lipid Metabolism and Ferroptosis During the Pathogenesis of Alzheimer’s Disease
Parisa Faraji, Hartmut Kühn, Shahin Ahmadian
Journal of Molecular Neuroscience (2024) Vol. 74, Iss. 3
Open Access | Times Cited: 7
Recent advances in LC-MS/MS methods to determine endocannabinoids in biological samples: Application in neurodegenerative diseases
Camila Marchioni, Israel Donizéti de Souza, Vinicius Ricardo Acquaro, et al.
Analytica Chimica Acta (2018) Vol. 1044, pp. 12-28
Closed Access | Times Cited: 55
Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases
Rosalba Leuci, Leonardo Brunetti, Viviana Poliseno, et al.
Foods (2020) Vol. 10, Iss. 1, pp. 29-29
Open Access | Times Cited: 43
Understanding the Modulatory Effects of Cannabidiol on Alzheimer’s Disease
Yinyi Xiong, Chae‐Seok Lim
Brain Sciences (2021) Vol. 11, Iss. 9, pp. 1211-1211
Open Access | Times Cited: 40
Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease
Leonardo Brunetti, Rosalba Leuci, Antonio Carrieri, et al.
European Journal of Medicinal Chemistry (2022) Vol. 237, pp. 114358-114358
Closed Access | Times Cited: 27
Modulating autophagy and mitophagy as a promising therapeutic approach in neurodegenerative disorders
Jayapriya Mishra, Gurjit Kaur Bhatti, Abhishek Sehrawat, et al.
Life Sciences (2022) Vol. 311, pp. 121153-121153
Closed Access | Times Cited: 25
Targeting the Nrf2 signaling pathway using phytochemical ingredients: A novel therapeutic road map to combat neurodegenerative diseases
Xue Bai, Zhigang Bian, Meng Zhang
Phytomedicine (2022) Vol. 109, pp. 154582-154582
Closed Access | Times Cited: 25
Amyotrophic Lateral Sclerosis and Pain: A Narrative Review from Pain Assessment to Therapy
Vincenzo Pota, Pasquale Sansone, Sara De Sarno, et al.
Behavioural Neurology (2024) Vol. 2024, pp. 1-23
Open Access | Times Cited: 5
Stimulation of S1PR5 with A-971432, a selective agonist, preserves blood–brain barrier integrity and exerts therapeutic effect in an animal model of Huntington’s disease
Alba Di Pardo, Salvatore Castaldo, Enrico Amico, et al.
Human Molecular Genetics (2018) Vol. 27, Iss. 14, pp. 2490-2501
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top